Carlo Contreras is an Oncology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 101 publications with 3,265 citations (h-index 27); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2050 Kenny Rd
Columbus, OH 432213502
Telephone
614-293-7171Provider last certified this registry record 28 Feb 2025.
Clinical trials
- Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study
Sponsor: Ohio State University Comprehensive Cancer Center
- EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
Sponsor: Ohio State University Comprehensive Cancer Center
- Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
Sponsor: Carlo Contreras
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Delcath SystemsProgram year20251 payment
- PFIZER INC.Program year20251 payment
- Delcath SystemsProgram year20247 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network
2025 - NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024
Journal of the National Comprehensive Cancer Network
2024 - Disparities in Survival and NCCN Guideline–Concordant Care in Patients With Extremity Soft Tissue Sarcoma
Journal of the National Comprehensive Cancer Network
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”